Supriya Lifescience Ltd.

Headquartered in Mumbai, India We are a Pure Play API Manufacturer & Suppliers

Leadership

Significant scale with leadership position in our therapeutic segments

Growing
Alliances

Global presence over 85+ countries with a growing customer base & establishing CDMO partnership

About Us

Supriya Lifescience Limited headquartered in Mumbai, India is a public listed generic pharmaceutical company established in 1987 dedicated to developing, commercializing APIs & FDFs to treat patients with various diseases and infections. The API facility located at Lote, Maharashtra, India is multiple times USFDA, EDQM/EUGMP approved, and Health Canada approved.

Watch Video

Area of Focus

API

FDF

CDMO

40+

Products

86+

Countries

1500+

Customers

22%

& above CAGR since 2019

400+

Employee Strength

We have a global footprint that extends across 86 countries

APIs

FDF

Awards

Latest News

02 February 2026

Health Sector Budget 2026 Live Updates: Biotech booster, Regulatory reset and Al

26 January 2026

Budget 2026 Expectations LIVE: Will Sitharaman's Union Budget Give Income Tax Relief To Taxpayers?

22 January 2026

API makers seek import curbs, GMP upgrade support in Budget 2026

09 January 2026

Ahead of union budget, pharma industry seeks R&D boost, GST rationalisation

08 January 2026

Supriya Lifescience ramps up capacity and global readiness for next phase of growth

06 January 2026

Supriya Lifescience bets on capex, new products to drive next growth phase

02 January 2026

Supriya Life Sciences bets on regulated markets with new facility

22 December 2025

Supriya Lifescience Targets Rs 1,600-Crore Revenue In 3 Years

Several awards for excellence and outstanding performance.

Established in the year 1987, Supriya Lifescience Ltd. is a global leading manufacturer of Active pharmaceutical Ingredients. Our state-of-the-art facility is certified by USFDA, EDQM, EUGMP, NMPA & Health Canada. Facility is located in Khed, District Ratnagiri and headquartered in Mumbai, India.